These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24745948)

  • 1. Sunsetting DSM-IV's pervasive developmental disorder.
    King BH
    J Am Acad Child Adolesc Psychiatry; 2014 May; 53(5):494-6. PubMed ID: 24745948
    [No Abstract]   [Full Text] [Related]  

  • 2. How to deal with the transition from Pervasive Developmental Disorders in DSM-IV to Autism Spectrum Disorder in DSM-V.
    Kurita H
    Psychiatry Clin Neurosci; 2011 Dec; 65(7):609-10. PubMed ID: 22176278
    [No Abstract]   [Full Text] [Related]  

  • 3. Sleep disturbance and its relation to DSM-IV psychiatric symptoms in preschool-age children with pervasive developmental disorder and community controls.
    DeVincent CJ; Gadow KD; Delosh D; Geller L
    J Child Neurol; 2007 Feb; 22(2):161-9. PubMed ID: 17621477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study on screening prevalence of pervasive developmental disorder in schoolchildren in Iran.
    Ghanizadeh A
    J Autism Dev Disord; 2008 Apr; 38(4):759-63. PubMed ID: 17879153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The autism spectrum disorder 'epidemic': Need for biopsychosocial formulation.
    Basu S; Parry P
    Aust N Z J Psychiatry; 2013 Dec; 47(12):1116-8. PubMed ID: 24168814
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitivity and specificity: DSM-IV versus DSM-5 criteria for autism spectrum disorder.
    Tsai LY
    Am J Psychiatry; 2012 Oct; 169(10):1009-11. PubMed ID: 23032376
    [No Abstract]   [Full Text] [Related]  

  • 7. DSM-IV supervisor voices concerns about the diagnostic manual.
    Kouros N
    Monash Bioeth Rev; 2013 Sep; 31(2):16-7. PubMed ID: 24844064
    [No Abstract]   [Full Text] [Related]  

  • 8. [DSM-5: neurodevelopmental disorders].
    Zinkstok J; Buitelaar J
    Tijdschr Psychiatr; 2014; 56(3):162-6. PubMed ID: 24643824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective long-term follow-up of patients with pervasive developmental disorders.
    Burd L; Kerbeshian J; Westerland A; Labine J; Barth A; Klug MG; Wagner K
    J Child Neurol; 2002 Sep; 17(9):681-8. PubMed ID: 12503645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing challenging behavior in children diagnosed with autism spectrum disorders according to the DSM-IV-TR and the proposed DSM-5.
    Beighley JS; Matson JL; Rieske RD; Jang J; Cervantes PE; Goldin RL
    Dev Neurorehabil; 2013 Dec; 16(6):375-81. PubMed ID: 23477536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on the application of DSM-5 criteria for autism spectrum disorder.
    Ritvo ER; Ritvo RA
    Am J Psychiatry; 2013 Apr; 170(4):444-5. PubMed ID: 23545801
    [No Abstract]   [Full Text] [Related]  

  • 12. Proposed criteria for autism spectrum disorder in the DSM-5.
    Hudziak JJ; Novins DK
    J Am Acad Child Adolesc Psychiatry; 2012 Apr; 51(4):343. PubMed ID: 22449637
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposed DSM-5 changes for autism spectrum disorder.
    Lohr WD; Le JF
    Pediatr Ann; 2012 Oct; 41(10):1-3. PubMed ID: 23052133
    [No Abstract]   [Full Text] [Related]  

  • 14. Criteria, categories, and continua: autism and related disorders in DSM-5.
    Happé F
    J Am Acad Child Adolesc Psychiatry; 2011 Jun; 50(6):540-2. PubMed ID: 21621137
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of pervasive developmental disorders in children and adolescents with mental retardation.
    de Bildt A; Sytema S; Kraijer D; Minderaa R
    J Child Psychol Psychiatry; 2005 Mar; 46(3):275-86. PubMed ID: 15755304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postponing the proposed changes in DSM 5 for autistic spectrum disorder until new scientific evidence adequately supports them.
    Ritvo ER
    J Autism Dev Disord; 2012 Sep; 42(9):2021-2. PubMed ID: 22825928
    [No Abstract]   [Full Text] [Related]  

  • 17. Thoughts on the DSM-5.
    Lecavalier L
    Autism; 2013 Sep; 17(5):507-9. PubMed ID: 24137734
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary from the DSM-5 Workgroup on Neurodevelopmental Disorders.
    Swedo SE; Baird G; Cook EH; Happé FG; Harris JC; Kaufmann WE; King BH; Lord CE; Piven J; Rogers SJ; Spence SJ; Wetherby A; Wright HH
    J Am Acad Child Adolesc Psychiatry; 2012 Apr; 51(4):347-9. PubMed ID: 22449639
    [No Abstract]   [Full Text] [Related]  

  • 19. DSM-5 and autism spectrum disorders: implications for families and clinicians.
    Coury DL
    J Dev Behav Pediatr; 2013 Sep; 34(7):494-6. PubMed ID: 24042080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of DSM-5 criteria on the developmental quotient in toddlers diagnosed with autism spectrum disorder.
    Turygin N; Matson JL; Beighley J; Adams H
    Dev Neurorehabil; 2013; 16(1):38-43. PubMed ID: 23031060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.